Observational studyBMC cancer2026

Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice.

Sara Vázquez-Quiroga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.